Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-0400-2024 — BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533

U.S. FDA — Device Enforcement · United States · 2023-10-04 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-0400-2024
Date of alert
2023-10-04
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
Becton Dickinson Infusion Therapy Systems Inc.
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
00382903825332
Reported risk: Over-the-needle, intravascular catheters may have needles that do not retract properly into the barrel, which could result in contaminated needlestick injury, blood leaking from the insertion site or catheter, and repeat catheter insertion attempts, due to catheter being inadvertently removed from the insertion site.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.